Showing 1381-1390 of 3082 results for "".
Pre-Treating Resectable Melanomas with PD-1 Inhibitors: An Emerging Strategy
https://practicaldermatology.com/topics/skin-cancer-photoprotection/pre-treating-resectable-melanomas-with-pd-1-inhibitors-an-emerging-strategy/20489/Pre-treatment with anti-PD1 agents may improve outcomes for some patients and provide prognostic clues.Histopathologic Assessment of Atypical Pigmented Lesions: Financial and Diagnostic Considerations
https://practicaldermatology.com/topics/skin-cancer-photoprotection/histopathologic-assessment-of-atypical-pigmented-lesions-financial-and-diagnostic-considerations/21335/Taking prospective deeper sections may prove more cost-efficient in the long-term.The American Academy of Dermatology Meeting in an Age of Contraction
https://practicaldermatology.com/topics/general-topics/the-american-academy-of-dermatology-meeting-in-an-age-of-contraction/21386/Coral Reefs Under Siege: Is Sunscreen to Blame?
https://practicaldermatology.com/topics/practice-management/coral-reefs-under-siege-is-sunscreen-to-blame/20543/What the science says about the effects of sunscreens on marine life.Viewpoints: When is it Enough?
https://practicaldermatology.com/topics/general-topics/viewpoints-when-is-it-enough/21104/As MOC concerns mount, one specialist is calling for a poll of dermatologists.Currents
https://practicaldermatology.com/topics/practice-management/currents/21227/Currents
https://practicaldermatology.com/topics/practice-management/currents/21497/Technology Forge Your PathA State of Transition for EHRs
https://practicaldermatology.com/topics/practice-management/a-state-of-transition-for-ehrs/22953/As practitioners await the next step in the larger implementation of this technology, an emphasis on utility is more important than ever.Therapeutics Update
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/theraputics-update/20510/New products and pharmacologic developmentsNews
https://practicaldermatology.com/topics/general-topics/news/21238/